Medicine
Acetazolamide 500 mg capsule
Acetazolamide 500 mg capsule is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Acetazolamide
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 30 capsules and 12 more
- Manufacturers
- Zydus LifesciencesIndiaMicro LabsIndiaAmerican Health PackagingAvPAK
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- S01EC01 Acetazolamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 April 2019
- Identifiers
- RxCUI 562524DailyMed set ID 4e8797d9-2e78-49e0-af25-ac5d1f792499, 78f78919-a6ba-4072-bc45-2ab3637ed894, 2c1d9078-c15f-4dce-bc26-edfa5400fa9b +2NDC 60687-578, 42571-243, 65841-762 +2Application ANDA205301, ANDA207401
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule in 1 bottle | 65841-762-01 | Zydus LifesciencesIndia | 10 April 2019 |
| 500 capsule in 1 bottle | 65841-762-05 | Zydus LifesciencesIndia | 10 April 2019 |
| 30 capsule in 1 bottle | 65841-762-06 | Zydus LifesciencesIndia | 10 April 2019 |
| 1000 capsule in 1 bottle | 65841-762-10 | Zydus LifesciencesIndia | 10 April 2019 |
| 90 capsule in 1 bottle | 65841-762-16 | Zydus LifesciencesIndia | 10 April 2019 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 65841-762-30 | Zydus LifesciencesIndia | 10 April 2019 |
| 1000 capsule in 1 bottle | 70710-1591-0 | Zydus LifesciencesIndia | 8 May 2019 |
| 100 capsule in 1 bottle | 70710-1591-1 | Zydus LifesciencesIndia | 8 May 2019 |
| 30 capsule in 1 bottle | 70710-1591-3 | Zydus LifesciencesIndia | 8 May 2019 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 70710-1591-4 | Zydus LifesciencesIndia | 8 May 2019 |
| 500 capsule in 1 bottle | 70710-1591-5 | Zydus LifesciencesIndia | 8 May 2019 |
| 90 capsule in 1 bottle | 70710-1591-9 | Zydus LifesciencesIndia | 8 May 2019 |
| 100 capsule in 1 bottle | 42571-243-01 | Micro LabsIndia | 1 December 2020 |
| 30 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack | 60687-578-21 | American Health Packaging | 27 October 2020 |
| 20 blister pack in 1 box / 1 capsule in 1 blister pack | 50268-042-12 | AvPAK | 20 July 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 July 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Acetazolamide
Clinical summary
Acetazolamide is a carbonic anhydrase inhibitor indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those, among other approved uses. MedsAcross supplies Acetazolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcetazolamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Acetazolamide prescribing information (Lifestar Pharma) · U.S. National Library of Medicine, DailyMed
Need Acetazolamide 500 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.